Published in Gene Therapy Weekly, May 18th, 2000
"Global perfusion (GP) and intramyocardial (IM) vector administration represent alternative strategies for cardiac gene therapy," said Leonard Y. Lee and colleagues from the New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, in a second presentation to the 49th Annual Scientific Session of the American College of Cardiology, held in Anaheim, California. "While IM delivery has been shown to provide high local transgene concentrations, GP delivery may be an ideal method of gene transfer when global treatment is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.